JESSICA ACKERMAN: Open Payments
NPI 1518383322 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,200 in 49 payments from 15 companies in 2025. Trend: 2023 $1,284 · 2024 $1,521 · 2025 $1,200
Food & beverage: $1,105Education: $95
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $210 |
| ABBVIE INC. | 10 | $171 |
| Novartis Pharmaceuticals Corporation | 4 | $134 |
| GENZYME CORPORATION | 3 | $105 |
| PFIZER INC. | 6 | $103 |
| Incyte Corporation | 4 | $84 |
| UCB, Inc. | 3 | $65 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $63 |
| Galderma Laboratories, L.P. | 2 | $61 |
| Arcutis Biotherapeutics, Inc. | 3 | $54 |
Products named: SKYRIZI, DUPIXENT, CIBINQO, OPZELURA, Rhapsido, ILUMYA, Bimzelx, Zoryve.
Industry payments across IL — which companies pay providers there.
